The United States of America; as represented by the Secretary; Department of Health and Human Serv
发明人:
Jeffrey Schlom,James W. Hodge
申请号：
US15507316
公开号：
US20170306042A1
申请日:
2015.08.28
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The invention is directed to methods of reducing growth of prostate cancer cells and breast cancer cells, which comprises treating such cancer cells with a combination of androgen or endocrine deprivation therapy (e.g., enzalutamide, abiraterone, and tamoxifen) and immunotherapy.
